Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Due to ESBL Escherichia Coli”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Not applicableEnded earlyNCT01820793
What this trial is testing

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

Who this might be right for
Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Assistance Publique - Hôpitaux de Paris 9
Not applicableUnknownNCT02456818
What this trial is testing

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

Who this might be right for
Oncology [See Also, Affected System]Hematological DiseaseInfection Due to ESBL Escherichia Coli
University of Cologne 2,264
Not applicableStudy completedNCT01961206
What this trial is testing

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Who this might be right for
Community Acquired Infection
Jian-cang Zhou M.D. 960
Post-approval studies (Phase 4)Temporarily pausedNCT03891433
What this trial is testing

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

Who this might be right for
Urinary Tract InfectionsEnterobacteriaceae InfectionsInfection Due to ESBL Bacteria+5 more
Universidad del Norte 198